HealthyNCT04600531
Conventional or High Definition tDCS to Enhance Implicit Motor Sequence Learning in Healthy Young Adults?
A study testing 1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS) and 4x1 Multichannel Stimulation Adapter for High Definition Transcranial Direct Current Stimulation (HD tDCS) in people with Healthy, run by Vrije Universiteit Brussel at 1 site in Belgium.
Trial summary
Implicit motor sequence learning (IMSL) is a form of cognitive function that is known to be directly associated with motor function. This hallmark motor skill enables humans to perform multiple single movements in a specific sequential order and is involved in many of our daily activities (e.g. Read more about this study
- Who is it for?
- Ages 18 to 35 yearsHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- 1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS) and 4x1 Multichannel Stimulation Adapter for High Definition Transcranial Direct Current Stimulation (HD tDCS)
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 90 participants
- Where
- 1 siteBelgium
- Study dates
- 15 Oct 2020to 15 Nov 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- no history of neurological and/or recent musculoskeletal diseases that could hamper the execution of the SRT-task.
Who cannot join
- any of the following tDCS contra-indications: deep brain stimulator; pacemaker; head wound; skin condition of the scalp; a history of epilepsy.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Conventional or High Definition Transcranial Direct Current Stimulation to Enhance Implicit Motor Sequence Learning in Healthy Young Adults?
Implicit motor sequence learning (IMSL) is a form of cognitive function that is known to be directly associated with motor function. This hallmark motor skill enables humans to perform multiple single movements in a specific sequential order and is involved in many of our daily activities (e.g. reaching, dressing, typing). One promising tool that has been shown to improve this type of learning in healthy young individuals, is transcranial direct current stimulation (tDCS). This non-invasive brain stimulation technique entails the administration of a weak electrical current at the scalp between two electrodes. To date, studies have almost exclusively investigated effects of conventional tDCS. Recently, however, novel High Definition (HD) tDCS devices have been commercialised. Whereas conventional tDCS uses two rather large electrodes, likely including adjacent cortical areas in the stimulation, HD-tDCS uses multiple smaller electrodes, allowing for stimulation of the targeted cortical region with higher resolution/specificity. The aim of the present study is to confirm previous findings suggesting beneficial effects of conventional tDCS, delivered over the primary motor cortex (M1) in healthy young adults. Additionally, the investigators will be the first to investigate potential effects of HD tDCS on IMSL in this population and to make a comparison between these two devices. The investigators will determine immediate effects that may occur concurrently with the application of tDCS but also short-term (five minutes post-tDCS) and long-term (one week post-tDCS) consolidation effects, as previous studies suggest that tDCS exerts its beneficial effects on IMSL in a consolidation phase rather than in an acquisition phase.
Read the detailed description
STUDY DESIGN
The investigators will conduct a single-blind, sham-controlled, counterbalanced study. For the sequence-specific aspect of IMSL (primary outcome), a mixed factorial repeated measures ANOVA will be carried out with "device" (2 levels: conventional tDCS, HD tDCS) as between-subjects factor and "stimulation" (2 levels: anodal, sham), "blocks" (2 levels: random block, mean of adjacent blocks) and "time" (3 levels: during, post5min, post1week) as within-subjects factors. Similarly, for general learning (secondary outcome), a mixed factorial repeated measures ANOVA will be executed with "device" (2 levels: conventional tDCS, HD tDCS) as between-subjects factor and "stimulation" (2 levels: anodal, sham), "blocks" (7 levels: Blocks 1-6, Block 8) and "time" (3 levels: during, post5min, post1week) as within-subjects factors. Participants are randomly assigned to either the conventional tDCS group or the HD tDCS group by block randomization. All participants will receive both anodal (real) and sham (placebo) tDCS in a random order. Counterbalancing will be done by an independent investigator using Microsoft Excel®.
RECRUITMENT STRATEGY
Healthy young adults will be recruited from the Vrije Universiteit Brussel. There are no restrictions or prohibitions for the subjects.
MATERIALS
For the Conventional tDCS, a 1x1 Low Intensity Direct Current Stimulator (Soterix Medical Inc, New York, USA) will be used to generate and deliver tDCS through a pair of identical square rubber electrodes (size 35 cm2), placed in rectangular saline-soaked sponges. For the stimulation of M1, electrodes will be placed over C3 or C4 according to the international 10-20 electroencephalogram system, matching with the M1 contralateral to the performing hand. The reference electrode will be positioned on F1 or F2, ipsilateral to the performing hand.
The current stimulation will be slowly ramped up from 0 milliampere (mA) to 2 mA in one minute. For the anodal tDCS condition, this intensity will be maintained for the duration of the SRT-task (approximately 20 minutes), which is well within evidence-based safety standards for tDCS. This will result in a current density of 0,057 mA/cm2. For the sham tDCS condition - unbeknown to the subject - stimulation will be gradually decreased towards 0 mA immediately after the one-minute ramp-up. During the last block of the SRT-task, this gradual ramping-up and -down of the current stimulation will be repeated to optimize the process of blinding of participants. To control for blinding of the subjects, after the last session subjects will be asked whether they were aware of the stimulation condition or not. Transient side-effects will be inventoried by the experimenter during and two weeks after the tDCS protocol, and may include a slight itching sensation under the electrode, redness of the skin under the electrode, headache, nausea, fatigue or insomnia.
For the High Definition tDCS, a 4x1 Multichannel Stimulation Adapter (Soterix Medical Inc, New York, USA) will be used to deliver HD tDCS over M1. By connecting the conventional tDCS device (described above) to this Multichannel Stimulation Adapter, the direct current is delivered along the 4x1 HD tDCS configuration, allowing for neuromodulation restricted to the desired area. In contrast to the relatively large sponge-electrodes used in conventional tDCS montages (Figure 1A), stimulation via HD tDCS is delivered by means of one central gel-electrode and four return-electrodes placed in plastic encasings embedded in an EEG cap (Figure 1B). Set-up of the device will be done according to the extensive experimental protocol provided by Villamar and colleagues (2013). For the stimulation of the left M1, contralateral to the performing right hand, the anodal stimulation will be delivered via the central electrode corresponding with C3 and held in place using the specially designed synthetic cap to hold the HD-tDCS electrodes on the head. The return-electrodes are positioned at Cz, F3, T7 and P3 (international 10-20 electroencephalogram system), see Figure 2. For the right M1, contralateral to the performing left hand, the central electrode will be positioned at C4 with the return-electrodes at Cz, F4, T8 and P4. The stimulating (anodal) direct current will be ramped up for 60 seconds to an intensity of 2 mA, and maintained for the duration of the SRT-task (about 20 minutes).
The Serial Reaction Time task (SRT-task) will be used to determine IMSL. The SRT- task will be performed on a laptop using E-Prime® software (Psychology Software Tools, Inc., Pittsburgh, Pennsylvania, USA). Participants will be asked to press the horizontally aligned response keys C, V, B, N of a standard azerty keyboard for a leftmost, left, right, rightmost target, respectively. Responses will be given with the index finger of the least affected hand in the case of the persons with PD and with the dominant hand in the case of the healthy controls. If both hands are equally affected in the persons with PD, the dominant hand will be used as well. The response keys C, V, B and N will be the only visible keys, all other keys will be covered.
PROCEDURE
The experiment will take place at a laboratory of the Vrije Universiteit Brussel (VUB) or in a silent room at the participant's home, under supervision of the investigator.
Following a screening session (T0), in which baseline demographic characteristics (gender, age, dominant hand) will be collected. Participants will be assigned to either the conventional tDCS group or the HD tDCS group and will be seen four times (T1-T4) over the course of minimally five to maximally eleven weeks. All four sessions will start with a practice SRT-task of one random block of 25 trials, followed by the actual experimental SRT-task of eight blocks of 72 trials with a thirty second break between consecutive blocks. In Blocks 1 through 6 and Block 8, the order of the target (i.e. black dot) locations will follow a repeating sequence. This is unbeknown to the participant. The rationale is that reaction times will decrease with repetition of the sequence throughout Blocks 1-6 and 8, denoting a general training effect (secondary outcome measure). When the repeating sequence suddenly changes to a random sequence in Block 7, reaction time will increase in Block 7 and decrease once more in regularly sequenced Block 8, denoting a sequence-specific learning effect (primary outcome measure). To control for possible carry-over effects, the SRT-task will follow a different sequence in each stimulation condition (e.g. 132342134142 in T1-T2 and 243413241213 in T3-T4). To make sure IMSL is independent of a specific sequence, six different, structurally identical, sequences of 12 elements long will be counterbalanced between the participants.
The first interventional session (T1) will be planned at least 1 week after the screening session (T0) and will consist of active (anodal) tDCS or sham (placebo) tDCS administered during the SRT-task. Five minutes post-tDCS, subjects will be asked to carry out a short, three-block version of the SRT-task without application of tDCS to investigate potential short-term consolidation effects: Blocks 1 and 3 following the same regular sequence as earlier; Block 2 following a random sequence.
The second session (T2) will be planned one week later. During this one-week post-tDCS session the same, full version of the SRT-task from one week earlier will be performed, this time without the application of tDCS, to determine potential long-term consolidation effects. After T2, a washout period of at least three weeks will be planned to control for carry-over effects between the two stimulation conditions (active/sham tDCS). Cross-over will take place and the same procedure with the opposite stimulation condition will be repeated during the third (T3) interventional and fourth (T4) follow-up session. Half of participants in each group will have received active tDCS during T1 and sham tDCS during T3, while the other half of participants will have received these conditions in reversed and randomized order.
The current stimulation will be slowly ramped up from 0 mA to 2 mA in one minute. For the anodal tDCS condition, this intensity will be maintained for the duration of the SRT-task (approximately 20 minutes), For the sham tDCS condition - unbeknown to the subject - stimulation will be gradually decreased towards 0 mA immediately after the one-minute ramp-up.
A post-SRT-task questionnaire will be completed after the last session (T4) to determine whether participants became aware of the sequential nature of the task. If participants indicate that they believe a specific sequence appeared, they will have to reproduce the sequence of the last session as correct as possible.
STATISTICAL ANALYSES
All statistical analyses will be carried out using International Business Machines (IBM) Statistical Package for the Social Sciences (SPSS) Statistics version 26. The level of significance will be set at α = 0.05. A trend towards significance will be defined as 0.05 ≤ α < 0.10. Appropriate corrections for multiple comparisons will be made when necessary. Cohen's f effect sizes will be reported, with values of .10, .25, and .40 representing small, medium, and large effect sizes, respectively.
In the event of null-effects, the investigators will conclude that there is no evidence of a difference between conditions. However, the investigators will also calculate post-hoc Bayes factors for each group (conventional tDCS, HD tDCS) to assess whether a lack of difference in sequence learning between the anodal and sham stimulation conditions could be interpreted as evidence for the absence of an effect of tDCS on sequence learning.
Correlation analyses, Bonferroni-corrected for multiple comparisons, will be performed to investigate if the amount of IMSL correlates with demographical, variables (including clinical subtypes of PD). If assumptions for parametrical testing are violated, the non-parametric alternative Spearman's Rho will be calculated.
The outcomes of the SRT-tasks during, at 5 minutes post and one week post sham tDCS will serve as baseline measures to be compared with the outcomes following actual anodal tDCS.
The analyses of the SRT-task performance will be based on median reaction time (RT) per block instead of mean RT to minimize potential outlier effects. Practice trials, the first response after each break, erroneous responses and responses following an error will be excluded from the analyses. Median RTs per block will be analyzed to determine (1) a general learning effect (secondary outcome measure) and (2) a sequence-specific learning effect (primary outcome measure).
General learning effects during and at one-week post-tDCS will be derived from a decline in median RTs over the seven regularly sequenced blocks (i.e. Blocks 1-6 and Block 8). This will not be applicable to the 5-minutes post-tDCS SRT-task as it is a short version with only three blocks. A 2x2x2x7 repeated measures ANOVA will be carried out with device (conventional tDCS, HD tDCS) as between-subjects factor and stimulation (active, sham), time (during, post1week) and block (Blocks 1-6, Block 8) as within-subjects factors.
Sequence-specific learning effects during, 5 minutes and 1 week post-tDCS will be analyzed by subtracting the mean of the median RTs of adjacent sequenced blocks (Blocks 6 and 8 during stimulation and at one week post-tDCS; Blocks 1 and 3 at 5 minutes post-tDCS) from the median RT of the random block (Block 7 during stimulation and at 1-week post-tDCS; Block 2 at 5-minutes post-tDCS). A 2x2x2x3 repeated measures ANOVA (or Friedman and Wilcoxon signed rank tests as non-parametrical alternatives) will be carried out with device (conventional tDCS, HD tDCS) as between-subjects factor and stimulation (active, sham), sequence (random block, mean of adjacent sequenced blocks) and time (during, post5min, post1week) as within-subject factors.
In case assumptions of sphericity are violated, Greenhouse-Geisser or Huynh-Feldt corrections will be reported. Bonferroni-corrected t-tests will be implemented to further analyze significant main and interaction effects.
Error percentages in the SRT-task are generally small and thus, because of a limited number of observations, less sensitive to IMSL. The percentage erroneous reactions per block will be calculated for both stimulation conditions (anodal, sham) and for the three measurements over time (concurrent, post5minutes, post1week). The Shapiro-Wilk test of residuals will be carried out to evaluate normality of distribution.
The sequential score, as outcome measure for explicit knowledge, will be taken up as a covariate in the analyses. An independent samples t-test (or non-parametrical alternative Mann-Whitney U test) will be carried out to ascertain whether the sequential scores (x/12) of the conventional tDCS group are different from the HD tDCS group.
- Conditions
- Healthy
- Being tested
- 1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS), 4x1 Multichannel Stimulation Adapter for High Definition Transcranial Direct Current Stimulation (HD tDCS)
- Keywords
- Healthy, Healthy Young Adults, Transcranial Direct Current Stimulation, tDCS, Serial Reaction Time Task, SRT Task, Sequence Learning, Procedural Learning, Implicit Learning, Implicit Motor Sequence Learning
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS)Device
tDCS will be delivered through a pair of identical square rubber electrodes (size 35 cm2), placed in rectangular saline-soaked sponges. For the stimulation of M1, electrodes will be placed over C3 or C4 according to the 10-20 EEG system, matching with the M1 contralateral to the performing dominant hand. The reference electrode will be positioned on F1 or F2, ipsilateral to the dominant hand.
The current stimulation will be slowly ramped up from 0 mA to 2 mA in one minute. For the anodal tDCS condition, this intensity will be maintained for the duration of the SRT-task (approximately 20 minutes). This will result in a current density of 0,057 mA/cm2. For the sham tDCS condition - unbeknown to the subject - stimulation will be gradually decreased towards 0 mA immediately after the one-minute ramp-up. During the last block of the SRT-task, this gradual ramping-up and -down of the current stimulation will be repeated to optimize the process of blinding of participants.
4x1 Multichannel Stimulation Adapter for High Definition Transcranial Direct Current Stimulation (HD tDCS)Device
HD tDCS will be delivered over M1. By connecting the conventional tDCS device (described above) to this "adapter", the direct current is delivered along the 4x1 HD tDCS configuration, allowing for more specific neuromodulation. Stimulation is delivered by means of one central gel-electrode and four return-electrodes placed in plastic encasings embedded in an EEG cap.
Stimulation of left M1 (right hand = performing): delivered via the central electrode corresponding with C3 and held in place using a synthetic cap to hold the HD-tDCS electrodes on the head. Return-electrodes are positioned at Cz, F3, T7 and P3 (10-20 EEG system).
Stimulation of right M1 (left hand = performing): central electrode will be positioned at C4 with the return-electrodes at Cz, F4, T8 and P4.
Strategies for anodal and sham stimulation are identical to the ones described above (conventional tDCS).
| Study group | Role | What they receive |
|---|---|---|
| Group 1a - Conventional tDCS - Anodal first | Experimental | Half of all subjects will receive Conventional tDCS (randomly assigned). Within this Conventional tDCS condition, half of the subjects will receive active (anodal, real) tDCS in the first session. Following cross-over and a three-week washout-period, this half of the subjects will receive sham (placebo) tDCS. Receives: Device: 1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS) |
| Group 1b - Conventional tDCS - Sham first | Sham comparator | Half of all subjects will receive Conventional tDCS (randomly assigned). Within this Conventional tDCS condition, half of the subjects will receive sham (placebo) tDCS in the first session. Following cross-over and a three-week washout-period, this half of the subjects will receive active (anodal, real) tDCS. Receives: Device: 1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS) |
| Group 2a - HD tDCS - Anodal first | Experimental | Half of all subjects will receive High Definition (HD) tDCS (randomly assigned). Within this HD tDCS condition, half of the subjects will receive active (anodal, real) tDCS in the first session. Following cross-over and a three-week washout-period, this half of the subjects will receive sham (placebo) tDCS. Receives: Device: 4x1 Multichannel Stimulation Adapter for High Definition Transcranial Direct Current Stimulation (HD tDCS) |
| Group 2b - HD tDCS - Sham first | Sham comparator | Half of all subjects will receive High Definition (HD) tDCS (randomly assigned). Within this HD tDCS condition, half of the subjects will receive sham (placebo) tDCS in the first session. Following cross-over and a three-week washout-period, this half of the subjects will receive active (anodal, real) tDCS. Receives: Device: 4x1 Multichannel Stimulation Adapter for High Definition Transcranial Direct Current Stimulation (HD tDCS) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sequence-Specific Learning Effect (during and following active tDCS)
In a typical SRT task, a target (e.g. black dot) is presented in one of four horizontal locations on a computer screen. Participants are asked to react to the target location by pressing a spatially compatible response key. Participants are not informed that the order of target locations follows a sequence predetermined by the experimenter. Participants are trained on the sequence in several blocks of trials, e.g.: 7 blocks of 100 trials. Typically, reaction times (RTs) decrease with practice, which is referred to as a general learning effect and constitutes the non-sequence-specific learning component of IMSL. Crucially, RTs increase when the sequence is inconspicuously replaced by a random sequence and decrease again when the predetermined sequence is reintroduced. The latter is referred to as the sequence-specific learning effect and is calculated by subtracting the mean RTs of the adjacent sequel blocks.
Measured: Changes in Sequence-Specific Learning Effect will be assessed between: (baseline) during active tDCS; (short-term) 5-minutes post active tDCS; (long-term) 1 week post active tDCS
Sequence-Specific Learning Effect (during and following sham tDCS)
In a typical SRT task, a target (e.g. black dot) is presented in one of four horizontal locations on a computer screen. Participants are asked to react to the target location by pressing a spatially compatible response key. Participants are not informed that the order of target locations follows a sequence predetermined by the experimenter. Participants are trained on the sequence in several blocks of trials, e.g.: 7 blocks of 100 trials. Typically, reaction times (RTs) decrease with practice, which is referred to as a general learning effect and constitutes the non-sequence-specific learning component of IMSL. Crucially, RTs increase when the sequence is inconspicuously replaced by a random sequence and decrease again when the predetermined sequence is reintroduced. The latter is referred to as the sequence-specific learning effect and is calculated by subtracting the mean RTs of the adjacent sequel blocks.
Measured: Changes in Sequence-Specific Learning Effect will be assessed between: (baseline) during sham tDCS; (short-term) 5-minutes post sham tDCS; (long-term) 1 week post sham tDCS
Secondary outcomes (2)
General Learning Effect (during and following active tDCS)
In the SRT-task, typically, reaction times (RTs) decrease with practice, which is referred to as a general learning effect and constitutes the non-sequence-specific learning component of IMSL.
Measured: Changes in General Learning Effect will be assessed between: (baseline) during active tDCS; (short-term) 5-minutes post active tDCS; (long-term) 1 week post active tDCS
General Learning Effect (during and following sham tDCS)
In the SRT-task, typically, reaction times (RTs) decrease with practice, which is referred to as a general learning effect and constitutes the non-sequence-specific learning component of IMSL.
Measured: Changes in General Learning Effect will be assessed between: (baseline) during sham tDCS; (short-term) 5-minutes post sham tDCS; (long-term) 1 week post sham tDCS
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Oct 2020
- Study start15 Oct 2020
- Primary completion15 Oct 2021
- Study completion15 Nov 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- sham-controlled, counterbalanced study
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 90 participants (actual)
Sponsor and investigators
- Lead sponsor
- Vrije Universiteit Brussel
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mahyar Firouzi, Vrije Universiteit Brussel
- Investigators
- Kris Baetens, PhD, Study chair, Vrije Universiteit Brussel - Brain Body and Cognition Research GroupChris Baeken, PhD, MD, Study chair, University GhentFrank Van Overwalle, PhD, Study chair, Vrije Universiteit Brussel - Brain Body and Cognition Research GroupEva Swinnen, PhD, Study chair, Vrije Universiteit Brussel - Rehabilitation Research GroupNatacha Deroost, PhD, Study director, Vrije Universiteit Brussel - Brain Body and Cognition Research GroupMahyar Firouzi, MSc, Principal investigator, Vrije Universiteit Brussel - Brain Body and Cognition Research Group
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04600531
- Sponsor's protocol ID
- B1432020000011
- Status last verified
- Nov 2021
- First submitted
- 16 Oct 2020
- Last updated
- 19 Nov 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 19 Nov 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Conventional or High Definition Transcranial Direct Current Stimulation to Enhance Implicit Motor Sequence Learning in Healthy Young Adults?
- ClinicalTrials.gov ID
- NCT04600531
- Acronym / sponsor ID
- B1432020000011
- Conditions
- Healthy
- Keywords
- Healthy, Healthy Young Adults, Transcranial Direct Current Stimulation, tDCS, Serial Reaction Time Task, SRT Task, Sequence Learning, Procedural Learning
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 90 participants (actual)
- Lead sponsor
- Vrije Universiteit BrusselUniversity, hospital or other
- Study start
- 15 Oct 2020 (actual)
- Primary completion
- 15 Oct 2021 (actual)
- Study completion
- 15 Nov 2021 (actual)
- First posted
- 23 Oct 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Implicit motor sequence learning (IMSL) is a form of cognitive function that is known to be directly associated with motor function. This hallmark motor skill enables humans to perform multiple single movements in a specific sequential order and is involved in many of our daily activities (e.g. reaching, dressing, typing). One promising tool that has been shown to improve this type of learning in healthy young individuals, is transcranial direct current stimulation (tDCS). This non-invasive brain stimulation technique entails the administration of a weak electrical current at the scalp between two electrodes. To date, studies have almost exclusively investigated effects of conventional tDCS. Recently, however, novel High Definition (HD) tDCS devices have been commercialised. Whereas conventional tDCS uses two rather large electrodes, likely including adjacent cortical areas in the stimulation, HD-tDCS uses multiple smaller electrodes, allowing for stimulation of the targeted cortical region with higher resolution/specificity. The aim of the present study is to confirm previous findings suggesting beneficial effects of conventional tDCS, delivered over the primary motor cortex (M1) in healthy young adults. Additionally, the investigators will be the first to investigate potential effects of HD tDCS on IMSL in this population and to make a comparison between these two devices. The investigators will determine immediate effects that may occur concurrently with the application of tDCS but also short-term (five minutes post-tDCS) and long-term (one week post-tDCS) consolidation effects, as previous studies suggest that tDCS exerts its beneficial effects on IMSL in a consolidation phase rather than in an acquisition phase.
Detailed description
STUDY DESIGN
The investigators will conduct a single-blind, sham-controlled, counterbalanced study. For the sequence-specific aspect of IMSL (primary outcome), a mixed factorial repeated measures ANOVA will be carried out with "device" (2 levels: conventional tDCS, HD tDCS) as between-subjects factor and "stimulation" (2 levels: anodal, sham), "blocks" (2 levels: random block, mean of adjacent blocks) and "time" (3 levels: during, post5min, post1week) as within-subjects factors. Similarly, for general learning (secondary outcome), a mixed factorial repeated measures ANOVA will be executed with "device" (2 levels: conventional tDCS, HD tDCS) as between-subjects factor and "stimulation" (2 levels: anodal, sham), "blocks" (7 levels: Blocks 1-6, Block 8) and "time" (3 levels: during, post5min, post1week) as within-subjects factors. Participants are randomly assigned to either the conventional tDCS group or the HD tDCS group by block randomization. All participants will receive both anodal (real) and sham (placebo) tDCS in a random order. Counterbalancing will be done by an independent investigator using Microsoft Excel®.
RECRUITMENT STRATEGY
Healthy young adults will be recruited from the Vrije Universiteit Brussel. There are no restrictions or prohibitions for the subjects.
MATERIALS
For the Conventional tDCS, a 1x1 Low Intensity Direct Current Stimulator (Soterix Medical Inc, New York, USA) will be used to generate and deliver tDCS through a pair of identical square rubber electrodes (size 35 cm2), placed in rectangular saline-soaked sponges. For the stimulation of M1, electrodes will be placed over C3 or C4 according to the international 10-20 electroencephalogram system, matching with the M1 contralateral to the performing hand. The reference electrode will be positioned on F1 or F2, ipsilateral to the performing hand.
The current stimulation will be slowly ramped up from 0 milliampere (mA) to 2 mA in one minute. For the anodal tDCS condition, this intensity will be maintained for the duration of the SRT-task (approximately 20 minutes), which is well within evidence-based safety standards for tDCS. This will result in a current density of 0,057 mA/cm2. For the sham tDCS condition - unbeknown to the subject - stimulation will be gradually decreased towards 0 mA immediately after the one-minute ramp-up. During the last block of the SRT-task, this gradual ramping-up and -down of the current stimulation will be repeated to optimize the process of blinding of participants. To control for blinding of the subjects, after the last session subjects will be asked whether they were aware of the stimulation condition or not. Transient side-effects will be inventoried by the experimenter during and two weeks after the tDCS protocol, and may include a slight itching sensation under the electrode, redness of the skin under the electrode, headache, nausea, fatigue or insomnia.
For the High Definition tDCS, a 4x1 Multichannel Stimulation Adapter (Soterix Medical Inc, New York, USA) will be used to deliver HD tDCS over M1. By connecting the conventional tDCS device (described above) to this Multichannel Stimulation Adapter, the direct current is delivered along the 4x1 HD tDCS configuration, allowing for neuromodulation restricted to the desired area. In contrast to the relatively large sponge-electrodes used in conventional tDCS montages (Figure 1A), stimulation via HD tDCS is delivered by means of one central gel-electrode and four return-electrodes placed in plastic encasings embedded in an EEG cap (Figure 1B). Set-up of the device will be done according to the extensive experimental protocol provided by Villamar and colleagues (2013). For the stimulation of the left M1, contralateral to the performing right hand, the anodal stimulation will be delivered via the central electrode corresponding with C3 and held in place using the specially designed synthetic cap to hold the HD-tDCS electrodes on the head. The return-electrodes are positioned at Cz, F3, T7 and P3 (international 10-20 electroencephalogram system), see Figure 2. For the right M1, contralateral to the performing left hand, the central electrode will be positioned at C4 with the return-electrodes at Cz, F4, T8 and P4. The stimulating (anodal) direct current will be ramped up for 60 seconds to an intensity of 2 mA, and maintained for the duration of the SRT-task (about 20 minutes).
The Serial Reaction Time task (SRT-task) will be used to determine IMSL. The SRT- task will be performed on a laptop using E-Prime® software (Psychology Software Tools, Inc., Pittsburgh, Pennsylvania, USA). Participants will be asked to press the horizontally aligned response keys C, V, B, N of a standard azerty keyboard for a leftmost, left, right, rightmost target, respectively. Responses will be given with the index finger of the least affected hand in the case of the persons with PD and with the dominant hand in the case of the healthy controls. If both hands are equally affected in the persons with PD, the dominant hand will be used as well. The response keys C, V, B and N will be the only visible keys, all other keys will be covered.
PROCEDURE
The experiment will take place at a laboratory of the Vrije Universiteit Brussel (VUB) or in a silent room at the participant's home, under supervision of the investigator.
Following a screening session (T0), in which baseline demographic characteristics (gender, age, dominant hand) will be collected. Participants will be assigned to either the conventional tDCS group or the HD tDCS group and will be seen four times (T1-T4) over the course of minimally five to maximally eleven weeks. All four sessions will start with a practice SRT-task of one random block of 25 trials, followed by the actual experimental SRT-task of eight blocks of 72 trials with a thirty second break between consecutive blocks. In Blocks 1 through 6 and Block 8, the order of the target (i.e. black dot) locations will follow a repeating sequence. This is unbeknown to the participant. The rationale is that reaction times will decrease with repetition of the sequence throughout Blocks 1-6 and 8, denoting a general training effect (secondary outcome measure). When the repeating sequence suddenly changes to a random sequence in Block 7, reaction time will increase in Block 7 and decrease once more in regularly sequenced Block 8, denoting a sequence-specific learning effect (primary outcome measure). To control for possible carry-over effects, the SRT-task will follow a different sequence in each stimulation condition (e.g. 132342134142 in T1-T2 and 243413241213 in T3-T4). To make sure IMSL is independent of a specific sequence, six different, structurally identical, sequences of 12 elements long will be counterbalanced between the participants.
The first interventional session (T1) will be planned at least 1 week after the screening session (T0) and will consist of active (anodal) tDCS or sham (placebo) tDCS administered during the SRT-task. Five minutes post-tDCS, subjects will be asked to carry out a short, three-block version of the SRT-task without application of tDCS to investigate potential short-term consolidation effects: Blocks 1 and 3 following the same regular sequence as earlier; Block 2 following a random sequence.
The second session (T2) will be planned one week later. During this one-week post-tDCS session the same, full version of the SRT-task from one week earlier will be performed, this time without the application of tDCS, to determine potential long-term consolidation effects. After T2, a washout period of at least three weeks will be planned to control for carry-over effects between the two stimulation conditions (active/sham tDCS). Cross-over will take place and the same procedure with the opposite stimulation condition will be repeated during the third (T3) interventional and fourth (T4) follow-up session. Half of participants in each group will have received active tDCS during T1 and sham tDCS during T3, while the other half of participants will have received these conditions in reversed and randomized order.
The current stimulation will be slowly ramped up from 0 mA to 2 mA in one minute. For the anodal tDCS condition, this intensity will be maintained for the duration of the SRT-task (approximately 20 minutes), For the sham tDCS condition - unbeknown to the subject - stimulation will be gradually decreased towards 0 mA immediately after the one-minute ramp-up.
A post-SRT-task questionnaire will be completed after the last session (T4) to determine whether participants became aware of the sequential nature of the task. If participants indicate that they believe a specific sequence appeared, they will have to reproduce the sequence of the last session as correct as possible.
STATISTICAL ANALYSES
All statistical analyses will be carried out using International Business Machines (IBM) Statistical Package for the Social Sciences (SPSS) Statistics version 26. The level of significance will be set at α = 0.05. A trend towards significance will be defined as 0.05 ≤ α < 0.10. Appropriate corrections for multiple comparisons will be made when necessary. Cohen's f effect sizes will be reported, with values of .10, .25, and .40 representing small, medium, and large effect sizes, respectively.
In the event of null-effects, the investigators will conclude that there is no evidence of a difference between conditions. However, the investigators will also calculate post-hoc Bayes factors for each group (conventional tDCS, HD tDCS) to assess whether a lack of difference in sequence learning between the anodal and sham stimulation conditions could be interpreted as evidence for the absence of an effect of tDCS on sequence learning.
Correlation analyses, Bonferroni-corrected for multiple comparisons, will be performed to investigate if the amount of IMSL correlates with demographical, variables (including clinical subtypes of PD). If assumptions for parametrical testing are violated, the non-parametric alternative Spearman's Rho will be calculated.
The outcomes of the SRT-tasks during, at 5 minutes post and one week post sham tDCS will serve as baseline measures to be compared with the outcomes following actual anodal tDCS.
The analyses of the SRT-task performance will be based on median reaction time (RT) per block instead of mean RT to minimize potential outlier effects. Practice trials, the first response after each break, erroneous responses and responses following an error will be excluded from the analyses. Median RTs per block will be analyzed to determine (1) a general learning effect (secondary outcome measure) and (2) a sequence-specific learning effect (primary outcome measure).
General learning effects during and at one-week post-tDCS will be derived from a decline in median RTs over the seven regularly sequenced blocks (i.e. Blocks 1-6 and Block 8). This will not be applicable to the 5-minutes post-tDCS SRT-task as it is a short version with only three blocks. A 2x2x2x7 repeated measures ANOVA will be carried out with device (conventional tDCS, HD tDCS) as between-subjects factor and stimulation (active, sham), time (during, post1week) and block (Blocks 1-6, Block 8) as within-subjects factors.
Sequence-specific learning effects during, 5 minutes and 1 week post-tDCS will be analyzed by subtracting the mean of the median RTs of adjacent sequenced blocks (Blocks 6 and 8 during stimulation and at one week post-tDCS; Blocks 1 and 3 at 5 minutes post-tDCS) from the median RT of the random block (Block 7 during stimulation and at 1-week post-tDCS; Block 2 at 5-minutes post-tDCS). A 2x2x2x3 repeated measures ANOVA (or Friedman and Wilcoxon signed rank tests as non-parametrical alternatives) will be carried out with device (conventional tDCS, HD tDCS) as between-subjects factor and stimulation (active, sham), sequence (random block, mean of adjacent sequenced blocks) and time (during, post5min, post1week) as within-subject factors.
In case assumptions of sphericity are violated, Greenhouse-Geisser or Huynh-Feldt corrections will be reported. Bonferroni-corrected t-tests will be implemented to further analyze significant main and interaction effects.
Error percentages in the SRT-task are generally small and thus, because of a limited number of observations, less sensitive to IMSL. The percentage erroneous reactions per block will be calculated for both stimulation conditions (anodal, sham) and for the three measurements over time (concurrent, post5minutes, post1week). The Shapiro-Wilk test of residuals will be carried out to evaluate normality of distribution.
The sequential score, as outcome measure for explicit knowledge, will be taken up as a covariate in the analyses. An independent samples t-test (or non-parametrical alternative Mann-Whitney U test) will be carried out to ascertain whether the sequential scores (x/12) of the conventional tDCS group are different from the HD tDCS group.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 4
- Model description
- sham-controlled, counterbalanced study
| Arm | Type | Receives |
|---|---|---|
| Group 1a - Conventional tDCS - Anodal first | Experimental | Device: 1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS)Half of all subjects will receive Conventional tDCS (randomly assigned). Within this Conventional tDCS condition, half of the subjects will receive active (anodal, real) tDCS in the first session. Following cross-over and a three-week washout-period, this half of the subjects will receive sham (placebo) tDCS. |
| Group 1b - Conventional tDCS - Sham first | Sham comparator | Device: 1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS)Half of all subjects will receive Conventional tDCS (randomly assigned). Within this Conventional tDCS condition, half of the subjects will receive sham (placebo) tDCS in the first session. Following cross-over and a three-week washout-period, this half of the subjects will receive active (anodal, real) tDCS. |
| Group 2a - HD tDCS - Anodal first | Experimental | Device: 4x1 Multichannel Stimulation Adapter for High Definition Transcranial Direct Current Stimulation (HD tDCS)Half of all subjects will receive High Definition (HD) tDCS (randomly assigned). Within this HD tDCS condition, half of the subjects will receive active (anodal, real) tDCS in the first session. Following cross-over and a three-week washout-period, this half of the subjects will receive sham (placebo) tDCS. |
| Group 2b - HD tDCS - Sham first | Sham comparator | Device: 4x1 Multichannel Stimulation Adapter for High Definition Transcranial Direct Current Stimulation (HD tDCS)Half of all subjects will receive High Definition (HD) tDCS (randomly assigned). Within this HD tDCS condition, half of the subjects will receive sham (placebo) tDCS in the first session. Following cross-over and a three-week washout-period, this half of the subjects will receive active (anodal, real) tDCS. |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- no history of neurological and/or recent musculoskeletal diseases that could hamper the execution of the SRT-task.
Key exclusion criteria (1 listed)
- any of the following tDCS contra-indications: deep brain stimulator; pacemaker; head wound; skin condition of the scalp; a history of epilepsy.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS)tDCS will be delivered through a pair of identical square rubber electrodes (size 35 cm2), placed in rectangular saline-soaked sponges. For the stimulation of M1, electrodes will be placed over C3 or C4 according to the 10-20 EEG system, matching with the M1 contralateral to the performing dominant hand. The reference electrode will be positioned on F1 or F2, ipsilateral to the dominant hand. The current stimulation will be slowly ramped up from 0 mA to 2 mA in one minute. For the anodal tDCS condition, this intensity will be maintained for the duration of the SRT-task (approximately 20 minutes). This will result in a current density of 0,057 mA/cm2. For the sham tDCS condition - unbeknown to the subject - stimulation will be gradually decreased towards 0 mA immediately after the one-minute ramp-up. During the last block of the SRT-task, this gradual ramping-up and -down of the current stimulation will be repeated to optimize the process of blinding of participants. | Device | Group 1a - Conventional tDCS - Anodal first, Group 1b - Conventional tDCS - Sham first |
| 4x1 Multichannel Stimulation Adapter for High Definition Transcranial Direct Current Stimulation (HD tDCS)HD tDCS will be delivered over M1. By connecting the conventional tDCS device (described above) to this "adapter", the direct current is delivered along the 4x1 HD tDCS configuration, allowing for more specific neuromodulation. Stimulation is delivered by means of one central gel-electrode and four return-electrodes placed in plastic encasings embedded in an EEG cap. Stimulation of left M1 (right hand = performing): delivered via the central electrode corresponding with C3 and held in place using a synthetic cap to hold the HD-tDCS electrodes on the head. Return-electrodes are positioned at Cz, F3, T7 and P3 (10-20 EEG system). Stimulation of right M1 (left hand = performing): central electrode will be positioned at C4 with the return-electrodes at Cz, F4, T8 and P4. Strategies for anodal and sham stimulation are identical to the ones described above (conventional tDCS). | Device | Group 2a - HD tDCS - Anodal first, Group 2b - HD tDCS - Sham first |
Primary outcome
Sequence-Specific Learning Effect (during and following active tDCS)
Time frame: Changes in Sequence-Specific Learning Effect will be assessed between: (baseline) during active tDCS; (short-term) 5-minutes post active tDCS; (long-term) 1 week post active tDCS
In a typical SRT task, a target (e.g. black dot) is presented in one of four horizontal locations on a computer screen. Participants are asked to react to the target location by pressing a spatially compatible response key. Participants are not informed that the order of target locations follows a sequence predetermined by the experimenter. Participants are trained on the sequence in several blocks of trials, e.g.: 7 blocks of 100 trials. Typically, reaction times (RTs) decrease with practice, which is referred to as a general learning effect and constitutes the non-sequence-specific learning component of IMSL. Crucially, RTs increase when the sequence is inconspicuously replaced by a random sequence and decrease again when the predetermined sequence is reintroduced. The latter is referred to as the sequence-specific learning effect and is calculated by subtracting the mean RTs of the adjacent sequel blocks.
Sequence-Specific Learning Effect (during and following sham tDCS)
Time frame: Changes in Sequence-Specific Learning Effect will be assessed between: (baseline) during sham tDCS; (short-term) 5-minutes post sham tDCS; (long-term) 1 week post sham tDCS
In a typical SRT task, a target (e.g. black dot) is presented in one of four horizontal locations on a computer screen. Participants are asked to react to the target location by pressing a spatially compatible response key. Participants are not informed that the order of target locations follows a sequence predetermined by the experimenter. Participants are trained on the sequence in several blocks of trials, e.g.: 7 blocks of 100 trials. Typically, reaction times (RTs) decrease with practice, which is referred to as a general learning effect and constitutes the non-sequence-specific learning component of IMSL. Crucially, RTs increase when the sequence is inconspicuously replaced by a random sequence and decrease again when the predetermined sequence is reintroduced. The latter is referred to as the sequence-specific learning effect and is calculated by subtracting the mean RTs of the adjacent sequel blocks.
2 secondary outcomes
General Learning Effect (during and following active tDCS)
Time frame: Changes in General Learning Effect will be assessed between: (baseline) during active tDCS; (short-term) 5-minutes post active tDCS; (long-term) 1 week post active tDCS
General Learning Effect (during and following sham tDCS)
Time frame: Changes in General Learning Effect will be assessed between: (baseline) during sham tDCS; (short-term) 5-minutes post sham tDCS; (long-term) 1 week post sham tDCS
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Nov 2021.
Related trials for Healthy
Not yet recruitingPhase 1
Dynamic Magnetic Resonance Imaging of Human Subarachnoid Space Using Intrathecal Gadolinium Contrast
Healthy Volunteers
RecruitingObservational study
Survey to Determine Incarcerated Persons' Views on Surrogate Decision Making
Healthy Volunteers
Active, not recruitingPhase 1
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults
Healthy
Not yet recruitingObservational study
Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Blood Donors, Apheresis
Recruiting
Metabolic Impact of VLCPUFA-Rich Fish Oil: A Clinical Study on Omega-3 Index Enhancement in Healthy Individuals
Fatty Acids, Omega-3, Fish Oils
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kris Baetens, PhD study chair
Vrije Universiteit Brussel - Brain Body and Cognition Research Group
Chris Baeken, PhD, MD study chair
University Ghent
Frank Van Overwalle, PhD study chair
Vrije Universiteit Brussel - Brain Body and Cognition Research Group
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing 1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS) and 4x1 Multichannel Stimulation Adapter for High Definition Transcranial Direct Current Stimulation (HD tDCS) in people with Healthy, run by Vrije Universiteit Brussel at 1 site in Belgium.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sequence-Specific Learning Effect (during and following active tDCS) (time frame: Changes in Sequence-Specific Learning Effect will be assessed between: (baseline) during active tDCS; (short-term) 5-minutes post active tDCS; (long-term) 1 week post active tDCS). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Nov 2021.